Investing News Network: Changing the Limitations of Cannabis Research
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.
Strainprint Opens its Ambassador Program With IMPACT Network
Strainprint™, the leader in cannabis data collection and strain efficacy reporting, is pleased to announce the launch of its Ambassador Research Program. The Strainprint Ambassador program is available to qualified researchers that use Strainprint’s revolutionary data gathering and analytics tools to conduct observational cannabis studies in relation to specific medical conditions.
Strainprint Expands Coverage With the Addition of Harvest Medicine
Strainprint™ Technologies Ltd. Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community PRESS RELEASE Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest […]
High Canada – Innovation Within The Industry
July 22, 2017 – Strainprint was recently featured in High Canada. Our story focused on innovation within the industry.
Strainprint Announces The Formation of A Board of Medical Advisors
Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Announces Partnership With Emblem Cannabis Corp.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint Closes Private Investment Round
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.